"Clinical neurorestorative cell therapies: Developmental process, curre" by Hongyun Huang, Lin Chen et al.

Article Title

Clinical neurorestorative cell therapies: Developmental process, current state and future prospective

Authors

Hongyun Huang, Institute of Neurorestoratology, The Third Medical Centre, Chinese PLA General Hospital, Beijing 100853, China Beijing Hongtianji Neuroscience Academy, Beijing 100144, China
Lin Chen, Department of Neurosurgery, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine Beijing 100007, China
Gengsheng Mao, Institute of Neurorestoratology, The Third Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
Hari Shanker Sharma, Int. Exp. CNS Injury & Repair, Neurobiology (MRC) & Neuroanatomy (UU), Uppsala University, University Hospital, Anesthesiology & Intensive Care Medicine, Dept. Surgical Sciences, Uppsala, Sweden

Keywords

cell therapy, mature/functional cells, neurorestoration, olfactory ensheathing cells, stem cell-derived cell therapy product

Abstract

Clinical cell therapies (CTs) for neurological diseases and cellular damage have been explored for more than 2 decades. According to the United States Food and Drug Administration, there are 2 types of cell categories for therapy, namely stem cell-derived CT products and mature/functionally differentiated cell-derived CT products. However, regardless of the type of CT used, the majority of reports of clinical CTs from either small sample sizes based on single-center phase 1 or 2 unblinded trials or retrospective clinical studies showed effects on neurological improvement and the ability to either partially or temporarily thwart the deteriorating cellular processes of the neurodegenerative diseases. There have been only a few prospective, multicenter, randomized, double- blind placebo-control clinical trials of CTs so far in this developing novel area that have shown negative results, and more clinical trials are needed. This will expand our knowledge in exploring the type of cells that yield promising results and restore damaged neurological structure and functions of the central nervous system based on higher level evidence-based medical data. In this review, we briefly introduce the developmental process, current state, and future prospective for clinical neurorestorative CT.

DOI

https://doi.org/10.26599/JNR.2020.9040009

Publisher

Tsinghua University Press

Recommended Citation

Hongyun Huang, Lin Chen, Gengsheng Mao et al. Clinical neurorestorative cell therapies: Developmental process, current state and future prospective. Journal of Neurorestoratology 2020, 8(2): 61-82.

Download

Request a Copy

Included in

Biomedical Engineering and Bioengineering Commons, Nervous System Diseases Commons, Neurology Commons, Neurosciences Commons, Neurosurgery Commons

COinS